MCD Inc.
Project Title: Accelerating the Reduction of Malaria Morbidity and Mortality Program (ARM3)
In October 2011, the United States Agency for International Development (USAID) and the President’s Malaria Initiative (PMI) awarded MCDI the Accelerating the Reduction of Malaria Morbidity and Mortality Program (ARM3).
In collaboration with PMI and USAID/Benin, ARM3 seeks to assist the Government of Benin (GOB) in improving malaria health outcomes in accordance with the NMCP’s guidelines and standards. The primary objective of ARM3 is to help the GOB achieve the PMI target of reducing malaria-associated mortality by 70% compared to pre-initiative levels in Benin. In support of this PMI objective, the ARM3 program’s specific goal is to increase coverage and use of key life-saving malaria interventions in support of Benin’s NMCP Strategy. ARM3 seeks to complements and leverage the efforts of USAID through its APC and ANCRE projects as well as other donors (GFATM, UNICEF, WHO) to reach the NMCP’s goals of eliminating malaria as a public health problem in Benin in 2030.
In 2018, the documentary "Reducing Malaria Morbidity and Mortality in Benin: the ARM3 Story" was produced and can be viewed here.
Publications on ARM3's achievements:
Key Achievements:
Countries: Benin
Partners: Benin National Malaria Control Program, Ministry of Health
Funder: USAID/PMI
Duration: 2011-2018